BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 775499)

  • 1. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kaneko T; Kosaka K
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog.
    Ribes G; Trimble ER; Blayac JP; Wollheim CB; Loubatières-Mariani MM
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E339-43. PubMed ID: 6144271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of somatostatin on pancreatic endocrine--experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs--(author's transl)].
    Nakabayashi H; Yoshimitsu K; Kishitani M; Ueda M; Kawato M
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):218-26. PubMed ID: 786754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration.
    Stagner JI; Samols E; Weir GC
    J Clin Invest; 1980 Apr; 65(4):939-42. PubMed ID: 6987271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats.
    Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1981 Mar; 20(3):217-22. PubMed ID: 6112185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas.
    Weigert N; Dollinger M; Schmid R; Schusdziarra V
    Diabetologia; 1992 Dec; 35(12):1133-9. PubMed ID: 1478364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine stimulates insulin, glucagon, and somatostatin release in the perfused chicken pancreas.
    Honey RN; Weir GC
    Endocrinology; 1980 Oct; 107(4):1065-8. PubMed ID: 6105951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon release induced by pancreatic nerve stimulation in the dog.
    Marliss EB; Girardier L; Seydoux J; Wollheim CB; Kanazawa Y; Orci L; Renold AE; Porte D
    J Clin Invest; 1973 May; 52(5):1246-59. PubMed ID: 4349486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a thiazide diuretic (hydroflumethiazide) and a loop diuretic (bumetanide) on the endocrine pancreas: studies in vitro.
    Hermansen K; Schmitz O; Mogensen CE
    Metabolism; 1985 Aug; 34(8):784-9. PubMed ID: 2862565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of growth hormone-releasing hormone stimulation of the endocrine pancreas: studies with alpha- and beta-adrenergic and cholinergic antagonists.
    Hermansen K; Kappelgaard AM
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):589-94. PubMed ID: 2883798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypothalamic factors on insulin and glucagon release from the islets of Langerhans.
    Moltz JH; Dobbs RE; McCann SM; Fawcett CP
    Endocrinology; 1977 Jul; 101(1):196-202. PubMed ID: 324754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
    Mandarino L; Stenner D; Blanchard W; Nissen S; Gerich J; Ling N; Brazeau P; Bohlen P; Esch F; Guillemin R
    Nature; 1981 May; 291(5810):76-7. PubMed ID: 6112710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J; Schatz H; Nierle C; Pfeiffer EF
    Horm Metab Res; 1975 Jul; 7(4):284-7. PubMed ID: 168138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas.
    Hermansen K; Kappelgaard AM; Esmann J; Orskov H
    Diabetes; 1986 Jan; 35(1):119-23. PubMed ID: 2866996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats.
    Seino Y; Seino S; Takemura J; Tsuda K; Nishi S; Ishida H; Seno M; Usami M; Ikeda M; Imura H
    Endocrinology; 1984 Feb; 114(2):457-61. PubMed ID: 6140160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.